Search results for: 'generic drug market'

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) comprise innovation insights across antibody and cellular therapies. The study also encompasses recent innovations in liquid biopsy tests, drug delivery and drug discovery platforms.The Life Science, Health & Wellness TOE will feature disruptive technology advan...

Scope of the report The research report includes the following segments: Product scope: Diesel Generator based Power rentals Geographic scope: Kingdom of Saudi Arabia (KSA) End-user scope: Utilities (SEC), Oil and Gas, Petrochemicals and Refining, Construction, Industrial, Metals and Mining, Malls and Commercial, Others (including events, labour...

03 Mar 2017  |  Global  |  Market Research

Global Biopharmaceutical Analytical Instrumentation Market, Forecast to 2022

Analytics Required for Biosimilar Drugs to Stimulate Market Growth

Infographics

×

The global biopharmaceutical analytical instrumentation market generated a revenue of $1,092 million in 2015 and is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2015 to 2022. The biosimilars segment, which is expected to reach $35 billion in 2025, will strongly drive the biopharmaceutical analytical instrumentation marke...

27 Nov 2024  |  Global  |  Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

Gen AI-based Solutions are Driving Transformational Growth across the Payer and Provider Ecosystem as Organizations Move from Identification to Implementation

Infographics

×

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journey. Gen AI seamlessly syncs with existing tools/IT ...

This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injectables, intravenous injectables, intramuscular injectables, and others. Major market challenges,...

According to the United Nations, 68% of the world’s population will be living in cities by 2050. Massive investments, developments, and population shifts will require smart security systems to ensure data privacy and cybersecurity of the urban population and digital assets. The US spent $409 billion from 2003 to 2024 on the agencies for immigratio...

This research service provides an outlook of the U.S. generic pharmaceuticals market and includes the unbranded generic drugs sold within the U.S. The research service provides a market overview, trends, competitive landscape, market forecasts, market share analysis, industry challenges and opportunities.

17 Mar 2015  |  Global  |  Market Research

Analysis of the Global Diabetes Drug Delivery Market

Future Options for End Users

Infographics

×

The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...